ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MARKSANS NEWS why is Marksans Pharma Limited price falling or rising

MARKSANS NEWS reasons for why stock price of Marksans Pharma Limited is falling or rising

MARKSANS Marksans Pharma is falling or rising technical reasons

Technical analysis forecast for Marksans Pharma Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Marksans Pharma MARKSANS at this time. Stock is falling and might fall more.

It appears as if Marksans Pharma MARKSANS gave a large move recently.

Stock of Marksans Pharma (MARKSANS) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...

My analysis of Marksans Pharma is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Marksans Pharma stays below 182.6, but if it comes above 182.6, then a intra day buy could be more profitable.
If you take a sell trade below 182.6, then use 182.6 as stoploss and 177.7 as target. However if you take a buy trade in Marksans Pharma, then use 182.6 as stoploss and 186.67 as target.

MARKSANS Marksans Pharma is falling or rising NEWS fundamental reasons

Company Announcement Marksans Pharma Limited has informed the Exchange about Transcript - NEWS as on 2025-11-21

Company Announcement Marksans Pharma Limited has informed the Exchange regarding a press release dated November 20, 2025, titled "Marksans Pharma Limited's wholly owned subsidiary Relonchem Limited receives Marketing Authorisation for its product Cetirizine Dihydrochloride 1 m - NEWS as on 2025-11-20

Company Announcement Marksans Pharma Limited has informed the Exchange regarding a press release dated November 19, 2025, titled "Marksans Pharma Limited s wholly owned subsidiary Marksans Pharma Inc. receives USFDA approval for Loperamide Hydrochloride Tablets USP, 2 mg (OTC) - NEWS as on 2025-11-19

Company Announcement Marksans Pharma Limited has informed the Exchange about Link of Recording - NEWS as on 2025-11-17

Company Announcement Marksans Pharma Limited has informed the Exchange regarding a press release dated November 10, 2025, titled " US FDA cGMP inspection at Company s 2nd manufacturing facility located at Plot No. A-1, Phase 1-A, Verna Industrial Estate, Verna, Goa, India conc - NEWS as on 2025-11-10

Company Announcement Marksans Pharma Limited has informed the Exchange regarding a press release dated November 05, 2025, titled "Marksans Pharma Limited s wholly owned subsidiary in UK, Relonchem Limited receives Marketing Authorization for its product Exemestane 25mg film-co - NEWS as on 2025-11-06

Company Announcement Marksans Pharma Limited has informed the Exchange regarding 'DISCLOSURE UNDER 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"'. - NEWS as on 2025-11-03

Company Announcement Marksans Pharma Limited has informed the Exchange about Schedule of a conference call for analysts and investors on Friday, November 14, 2025 at 05:00 PM (IST) to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the - NEWS as on 2025-10-31

Company Announcement Marksans Pharma Limited has informed the Exchange about voluntary ESG rating assigned by CFC Finlease Private Limited. - NEWS as on 2025-10-27

Board Meeting to discuss Financial Results To consider and approve the financial results for the period ended September 30, 2025 - NEWS as on 2025-10-24

Company Announcement - NEWS as on 2025-10-24

Company Announcement Marksans Pharma Limited has informed the Exchange regarding a press release dated October 15, 2025, titled "Marksans Pharma Ltd's wholly owned subsidiary Relonchem Limited receives Marketing Authorisation for its products from UK MHRA". - NEWS as on 2025-10-15

More announcements and NEWS

MARKSANS Marksans Pharma Limited current price & indicator signals

Moving Averages for Marksans Pharma Limited

  • 5Day Average: 183.35
  • 12Day Average: 187.06
  • 20Day Average: 187.82
  • 50Day Average: 186.59
  • 100Day Average: 183.76
  • 150Day Average: 206.3
  • 200Day Average: 209.2

MARKSANS Indicators & signals

Indicator MACD (12,26,9)

185.71, 186.8, -0.13
Indicator MACD is in negative zone

Indicator ADX (14)

11.42, 17.73, 22.3
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 56
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MARKSANS Marksans Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
24 Wed Dec 2025 182.22 181.40 to 185.90 -0.31% 0.78 times
23 Tue Dec 2025 182.79 181.72 to 187.01 -2.45% 0.98 times
22 Mon Dec 2025 187.38 183.50 to 188.40 2.49% 0.77 times
19 Fri Dec 2025 182.82 181.71 to 185.40 0.71% 0.89 times
18 Thu Dec 2025 181.54 180.54 to 184.01 -0.94% 0.6 times
17 Wed Dec 2025 183.26 182.04 to 188.16 -1.98% 0.84 times
16 Tue Dec 2025 186.97 185.20 to 190.50 -1.91% 1.98 times
15 Mon Dec 2025 190.61 189.23 to 194.50 -1.68% 0.73 times
12 Fri Dec 2025 193.86 191.30 to 194.30 1.02% 0.91 times
11 Thu Dec 2025 191.90 189.01 to 193.25 0.36% 0.85 times
10 Wed Dec 2025 191.21 187.24 to 192.30 0.58% 1.44 times
09 Tue Dec 2025 190.11 180.85 to 191.80 3.21% 1.62 times

Videos related to: MARKSANS NEWS why is Marksans Pharma Limited price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

MARKSANS NEWS why is Marksans Pharma Limited price falling or rising

 

Back to top